Viewing Study NCT06996132


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-30 @ 3:36 AM
Study NCT ID: NCT06996132
Status: RECRUITING
Last Update Posted: 2025-06-17
First Post: 2025-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module